43.00% -0.045

Vincerx Pharma Inc (VINC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Layoff Tracker: IGM Axes 80% of Workforce - BioSpace

Stock Market Recap: Vincerx Pharma Inc (VINC) Concludes at 0.26, a 1.11 Surge/Decline - DWinneX

Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com

Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX

Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com

Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister

Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga

The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com

VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India

Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView

Vincerx Pharma announces plan to delist from Nasdaq - TipRanks

Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire

Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Increases By 99.4% - The AM Reporter

vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India

Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga

Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada

Crude Oil Down 4%; Neogen Shares Plunge After Q3 ResultsBloom Energy (NYSE:BE), Neogen (NASDAQ:NEOG) - Benzinga

Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals

Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks

Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times

Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com

Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener

Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa

Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World

Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView

Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register

Ähnlich wie VINC